Organizer
Phenomenex
Phenomenex
Phenomenex is a global technology leader committed to developing novel analytical chemistry solutions that solve the separation and purification challenges of researchers in industrial, government and academic laboratories. From drug discovery and pharmaceutical development to disease diagnosis, food safety to environmental analysis, Phenomenex chromatography solutions accelerate science and help researchers improve global health and well-being.
Tags
Tips & Tricks
HPLC
LinkedIn Logo

Allowed Adjustments to Pharmacopeia HPLC Methods

RECORD | Already taken place Tu, 25.7.2023
This webinar will provide a detailed understanding of new revisions to allowed adjustments for USP and Ph. Eur. HPLC methods through the use of case studies.
Go to the webinar
Phenomenex: Allowed Adjustments to Pharmacopeia HPLC Methods
Phenomenex: Allowed Adjustments to Pharmacopeia HPLC Methods

This webinar will provide a detailed understanding of new revisions to allowed adjustments for USP and Ph. Eur. HPLC methods through the use of case studies.

  • Intro: Review revisions to allowed adjustments for USP and Ph. Eur.
  • Isocratic Case Study: Adjustments to column length and ID, particle size, and flow rate
  • Gradient Case Study: Adjustments to column length and ID, particle size, flow rate, and gradient timetable

Key Learning Points:

  • Review of recent revision to allowed adjustments for USP and Ph. Eur. HPLC methods
  • Utilize a case study to highlight the approach for making adjustments to an isocratic method and the resulting benefits
  • Understand the benefits of working within the allowed adjustments for improving the performance of compendial HPLC methods (isocratic and gradient) in your laboratory

Who Should Attend:

Scientists and analysts in the pharmaceutical industry who work with Pharmacopeia HPLC methods that are interested in:

  • Improving performance
  • Reducing analysis time
  • Understanding allowable adjustment application examples

Presenter: Phil Koerner (Global Pharmaceutical Market Development Manager, Phenomenex)

Phenomenex
LinkedIn Logo
 

Related content

Simultaneous Quantitation and Discovery analysis: Combining targeted and untargeted metabolomics on Orbitrap mass spectrometers

Applications
| 2026 | Thermo Fisher Scientific
Instrumentation
LC/MS, LC/MS/MS, LC/Orbitrap, LC/HRMS
Manufacturer
Thermo Fisher Scientific
Industries
Metabolomics

Analysis of Per- and Polyfluoroalkyl Substances (PFAS) in Wastewater

Applications
| 2026 | Agilent Technologies
Instrumentation
LC/MS, LC/MS/MS, LC/QQQ
Manufacturer
Agilent Technologies
Industries
Environmental

Non-Targeted Screening of Biosolids with the Xevo™ MRT Mass Spectrometer Reveals New Isoforms of PFAS

Applications
| 2026 | Waters
Instrumentation
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS
Manufacturer
Waters
Industries
Environmental

High Resolution Characterization of Lipid Nanoparticles Using the Xevo™ Charge Detection Mass Spectrometry (CDMS) Instrument - Single Particle Mass Analysis of Intact LNP-mRNA Formulations

Applications
| 2026 | Waters
Instrumentation
LC/MS, LC/MS/MS, LC/HRMS, Particle characterization, LC/IT
Manufacturer
Waters
Industries
Lipidomics

Out-of-the-box workflow for PFAS quantitation using a fullscan high-resolution approach with the Orbitrap Exploris EFOX Mass Detector

Applications
| 2025 | Thermo Fisher Scientific
Instrumentation
LC/MS, LC/MS/MS, LC/Orbitrap, LC/HRMS
Manufacturer
Thermo Fisher Scientific
Industries
Environmental
Other projects
GCMS
ICPMS
Follow us
FacebookX (Twitter)LinkedInYouTube
More information
WebinarsAbout usContact usTerms of use
LabRulez s.r.o. All rights reserved. Content available under a CC BY-SA 4.0 Attribution-ShareAlike